Inventor
GRAY NATHANAEL
US38 patents
⚠️ This page may combine multiple inventors who share the name “GRAY NATHANAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
28 patentsUS9505784B2Nov 29, 2016
Fused 2-aminothiazole compounds
DANA FARBER CANCER INST INC64 citations97
US10112927B2Oct 30, 2018
Inhibitors of cyclin-dependent kinase 7 (CDK7)
DANA FARBER CANCER INST INC19 citations94
US9783504B2Oct 10, 2017
Kinase inhibitors for the treatment of disease
DANA FARBER CANCER INST INC21 citations94
US9382239B2Jul 5, 2016
Inhibitors of c-Jun-N-terminal kinase (JNK)
DANA FARBER CANCER INST INC30 citations94
US9758522B2Sep 12, 2017
Hydrophobically tagged small molecules as inducers of protein degradation
DANA FARBER CANCER INST INC27 citations93
US10144730B2Dec 4, 2018
Inhibitors of c-Jun-N-terminal kinase (JNK)
DANA FARBER CANCER INST INC16 citations92
US9358231B2Jun 7, 2016
Type II RAF kinase inhibitors
DANA FARBER CANCER INST INC22 citations91
US10047070B2Aug 14, 2018
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
DANA FARBER CANCER INST INC17 citations85
US10544138B2Jan 28, 2020
Tricyclic kinase inhibitors of MELK and methods of use
DANA FARBER CANCER INST INC12 citations84
US10316002B2Jun 11, 2019
Kinase inhibitors for the treatment of disease
DANA FARBER CANCER INST INC9 citations84
US10000483B2Jun 19, 2018
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
DANA FARBER CANCER INST INC18 citations81
US10787436B2Sep 29, 2020
Inhibitors of cyclin-dependent kinase 7 (CDK7)
DANA FARBER CANCER INST INC5 citations73
US10906889B2Feb 2, 2021
Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)
DANA FARBER CANCER INST INC4 citations72
US11530219B2Dec 20, 2022
Ligands to cereblon (CRBN)
DANA FARBER CANCER INST INC3 citations71
US10450310B2Oct 22, 2019
Bifunctional molecules for degradation of EGFR and methods of use
DANA FARBER CANCER INST INC5 citations71
US9725425B1Aug 8, 2017
Compounds and methods for treating cancer
DANA FARBER CANCER INST INC2 citations71
US11771697B2Oct 3, 2023
Small molecule degraders of polybromo-1 (PBRM1)
DANA FARBER CANCER INST INC0 citations61
US12110292B2Oct 8, 2024
Ligands to cereblon (CRBN)
DANA FARBER CANCER INST INC0 citations60
US11161842B2Nov 2, 2021
Bifunctional molecules for degradation of EGFR and methods of use
DANA FARBER CANCER INST INC0 citations60
US10875844B2Dec 29, 2020
Salicylate inhibitors of MELK and methods of use
DANA FARBER CANCER INST INC0 citations51
US12227488B2Feb 18, 2025
Small molecule degraders of Helios and methods of use
DANA FARBER CANCER INST INC0 citations50
US10787455B2Sep 29, 2020
Small molecule myristate inhibitors of BCR-ABL and methods of use
DANA FARBER CANCER INST INC0 citations50
US12234220B2Feb 25, 2025
Immunomodulatory compounds
DANA FARBER CANCER INST INC0 citations49
US12060366B2Aug 13, 2024
Bispecific degraders
DANA FARBER CANCER INST INC0 citations49
US12030892B2Jul 9, 2024
CRBN modulators
DANA FARBER CANCER INST INC0 citations49
US12466809B2Nov 11, 2025
CDK2/5 degraders and uses thereof
DANA FARBER CANCER INST INC0 citations48
US12365696B2Jul 22, 2025
Small-molecule focal adhesion kinase (FAK) inhibitors
DANA FARBER CANCER INST INC0 citations44
US10723753B2Jul 28, 2020
Ras inhibitors and uses thereof
DANA FARBER CANCER INST INC0 citations38